BioAmp Diagnostics

Berkeley, United States Founded: 2017 • Age: 9 yrs
Developers of diagnostic tests that help to treat patient with a specific antibiotic

About BioAmp Diagnostics

BioAmp Diagnostics is a Healthcare company based in Berkeley (United States) founded in 2017 by Nicole Tarlton. Developers of diagnostic tests that help to treat patient with a specific antibiotic. BioAmp Diagnostics offers products and services including DETECT Technology. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Assays and Drug Discovery. Its competitors include Lodestone Biomedical, Araceli Biosciences and ThinkSense; 2 of its 3 listed competitors have raised funding.

Company details

BioAmp Diagnostics was founded in 2017 in Berkeley, United States, within the biotechnology sector. Diagnostic tests are created to detect resistance biomarkers directly from patient samples, enabling physicians to select suitable antibiotics initially. Operations focus on improving treatment accuracy through targeted identification, with the company led by co-founder Nicole Tarlton. Services support clinical decision-making in infectious disease management.

  • Headquarters Berkeley, United States
  • Founders Nicole Tarlton
  • Sectors
    Healthcare
  • Website bioampdx.com
  • Social LinkedIn X
Key Metrics
  • Latest Funding Round
    $243.81K (USD), Grant

    Apr 2024

  • Investors
    Illumina

    & 3 more

Products & Services of BioAmp Diagnostics

BioAmp Diagnostics offers a comprehensive portfolio of products and services, including DETECT Technology.

DETECT Technology
Diagnostic Tool

Rapid chemistry-based system for quick infection detection and antibiotic guidance.

Funding Insights of BioAmp Diagnostics

  • Total Rounds 5
  • Last Round Grant — $243,806
  • Investors Count 4

All 5 funding rounds of BioAmp Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2024$243,806Grant––
May 2021$224,966Grant––
May 2020$224,996Grant––
Apr 2019Seed–Illumina
–
Jun 2017Seed–CITRIS Foundry
–
Valuation history

4 investors in total: 4 institutional.

Investors in BioAmp Diagnostics

BioAmp Diagnostics has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Illumina, National Science Foundation and America’s Seed Fund.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Venture capital fund backed by the US Government
seedfund.nsf.govAlexandria, United States
Startup accelerator program is backed by University of California.
citrisfoundry.orgBerkeley, United States
A government-backed foundation providing seed-stage investments to support small businesses.
1950nsf.govArlington, United States
Developer of technologies for analysis of genetic variation and function
1993illumina.comSan Diego, United States
Premium access

Investor details for BioAmp Diagnostics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of BioAmp Diagnostics

4 people are tracked at BioAmp Diagnostics (3 in leadership, 1 in team).

NameRoleGroup
Nicole Tarlton
Co-FounderLeadership
Tara deBoer, PhD (She/her)
Founder, CEOLeadership
Angel Resendez
Head Of ChemistryLeadership
Isha Kane
Business Strategy SpecialistTeam
Premium access

Complete people profiles for BioAmp Diagnostics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of BioAmp Diagnostics

3 dated milestones of BioAmp Diagnostics across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded BioAmp Diagnostics is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Grant, of $244K.

Competitors of BioAmp Diagnostics

BioAmp Diagnostics has 3 listed competitors in our database, 2 of them funded. They include Lodestone Biomedical, Araceli Biosciences and ThinkSense.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
lodestonebiomedical.com2015Hanover, United States$1.19M
Provider of magnetic nanoparticle platform technology for in vivo biomarker monitoring in immuno-oncology
aracelibio.com2020United States$15.95M
Scientific tools for tissue and cell-based biomarker discovery are developed.
thinksense.com2004Mclean, United States
Develops sensors for behavioral health data collection and analysis in trials.
Premium access

Detailed competitors of BioAmp Diagnostics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as BioAmp Diagnostics (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about BioAmp Diagnostics

BioAmp Diagnostics was founded in 2017.

BioAmp Diagnostics is headquartered in Berkeley, United States. It is registered at Berkeley, California, United States.

BioAmp Diagnostics was founded in 2017 in Berkeley, United States, within the biotechnology sector. Diagnostic tests are created to detect resistance biomarkers directly from patient samples, enabling physicians to select suitable antibiotics initially. Operations focus on improving treatment accuracy through targeted identification, with the company led by co-founder Nicole Tarlton. Services support clinical decision-making in infectious disease management.

BioAmp Diagnostics's top competitors include Araceli Biosciences, Lodestone Biomedical and ThinkSense.

BioAmp Diagnostics offers DETECT Technology.

BioAmp Diagnostics has 4 investors. Key investors include Illumina, National Science Foundation, America’s Seed Fund, and CITRIS Foundry.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available